By Klaus Ullherr
Cytostatic agents are used to treat cancer and autoimmune diseases and are among the most complex and delicate drugs. The active ingredients consist of cell poison; highly potent substances which interfere with the growth of cancer cells and inhibit cell division. Regarding production and handling, the highest quality requirements apply.
“Protecting the pharmaceuticals against contamination and ensuring operator safety have equally high priority when filling cytostatic drugs,” explains Saskia Killer, responsible for the syringe filling line at Oncotec Pharma Produktion in Dessau-Rosslau, Germany. “The filling technology must be able to minimize the risk of contamination through highly automated processes. Therefore, all components of the line must be exactly aligned to one another.”